ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ALL Atlantic Lithium Limited

21.20
-0.05 (-0.24%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Atlantic Lithium Limited LSE:ALL London Ordinary Share AU0000237554 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -0.24% 21.20 21.20 21.55 21.75 21.05 21.75 237,277 16:35:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Iron Ores 0 -12.19M -0.0200 -10.53 128.25M
Atlantic Lithium Limited is listed in the Iron Ores sector of the London Stock Exchange with ticker ALL. The last closing price for Atlantic Lithium was 21.25p. Over the last year, Atlantic Lithium shares have traded in a share price range of 16.48p to 35.00p.

Atlantic Lithium currently has 609,241,660 shares in issue. The market capitalisation of Atlantic Lithium is £128.25 million. Atlantic Lithium has a price to earnings ratio (PE ratio) of -10.53.

Atlantic Lithium Share Discussion Threads

Showing 101 to 124 of 4300 messages
Chat Pages: Latest  16  15  14  13  12  11  10  9  8  7  6  5  Older
DateSubjectAuthorDiscuss
16/3/2010
11:54
jakleeds-Thanks for your continued interest over at WSI.
Did you see my further posting re Infor !!?(AWESOME++)
I could be mudleeds by the way.

mudbath
10/3/2010
13:30
They've never given figures with their quarterly updates. Not many AIM stocks give quarterly updates so we can't really complain I suppose.
wjccghcc
10/3/2010
12:29
Awesome-maybe! Trouble is there are no figures to show growth or otherwise.Not a single statistic that I could see in the statement showing contract values or comparisons with any other period. So you have to take the "many many words" at face value which may indeed be a brilliant performance --but is it? Not suggesting they have taken PR guidance from Gordon Brown but it seems a bit close!

While I too feel sure the company is doing well, how do you proceed from here? My guess is just have to see whether the house broker edges up his profit forecast or, failing that, see whether the co issues a profits upgrade as it goes into into close season.

Rather hope that Gartmore's reduction in holding is just to reduce it below 15% overall. That could be the implication of the last small sale-- but not calling it.

gregmorg
10/3/2010
07:12
Morning All
Excellent Update this morning.

robward
09/3/2010
12:33
Gartmore disposes of another 150,000.
jakleeds
06/3/2010
18:36
Exactly when are due an update anyone?
jeanesy
05/3/2010
11:09
Hi Rob,
You are absolutely right on the first two points and, I hope, also right on the third point! I will be interested in the 3rd qtr update and which, given the other positive moves in recent time, I cannot help but conclude will be positive.
It is nice to see this starting to become a bulked up company ie well spread and not dependant on a few contracts. It has come a long way from when I first invested on the float. It was then only £2.4m market cap (and at 97p if my memory is not playing tricks !)and a full market listing(run by a strange bunch of private company characters who all faded as R Drummond found out what he had- and found out exactly in time-hence the rescues!

If that 25% growth rate can be sustained over the next year or so then a premium rating should follow. The market cap is approaching the £50m mark and should move thru it and widen the following as it moves away from very small cap status.

The recent appointment of an international finance officer/director highlights to everyone it is going to do bigger deals. Synergies should flow of course but these things not only have to be carefully bought but they have to be managed. Added complications come when a company goes on the acq trail as prices paid have to include a sellers' premium and certainly over book(if not- why not!). The problem then is that accountancy rules mean you have to write down against profit thereby masking some of the benefit. Having said all this it is nice to see a sensible bulletin board. Not many around. Thanks.

gregmorg
04/3/2010
19:28
Hi Greg
I'm not concerned about some institutions lowering their holdings mainly because the share price has been rising whilst they have been off-loading which suggests to me that there is another institution or perhaps a another software company building a position. The raising tax charge masks the excellent operational performance of the business with profits growing at over 25% a year and set to continue. I think the concern over potential cut-backs in the NHS is overdone because Allocate actually help Trusts manage their resources more efficently. We are due a 3rd Quarter Update very shortly.

Regards

Rob Ward (Shareholder for over 6 years !!)

robward
04/3/2010
15:15
After all these years that would be nice-actually really nice. Unfortunately Gartmore does not, or no longer shares, such optimisim! Hopefully it is a top slice or reduction to below 15% overall. Trouble is with institutions you can never be sure. After all why should they reveal their intent when it could work against their investor's returns.

Still as long as the company can sustain operating momentum everything else works out in time.

gregmorg
03/3/2010
17:05
Hopefully we can break above the old high from 2007, then clear skies, onwards and upwards.
the shuffle man
03/3/2010
16:22
Blimey are we breaking out- seems to be some interest in these all of a sudden.


Fantastic.

jakleeds
02/3/2010
17:49
I guess those two buys of 150000 shares each explain the rise. Long may it continue.
jakleeds
02/3/2010
09:44
And a nice tick up. Looking ripe for another surge.
jakleeds
02/3/2010
07:56
Allocate Software signs four NHS Trusts to use the recently launched e-Rostering for Doctors Solution to improve safety and deliver efficiency savings.

01 March 2010

Allocate Software is delighted to announce that East Cheshire NHS Trust, Mid Yorkshire NHS Trust, Shrewsbury and Telford Hospital NHS Trust and Leeds Teaching Hospitals NHS Trust have all recently selected MAPS Healthroster to manage the time of their medical staff and junior doctors more effectively. They join a growing community of NHS Trusts who are now using MAPS Healthroster to effectively roster multiple staffing groups, to achieve: effective management of substantive and locum medical staff; full compliancy with EWTD and New Deal; alignment of doctor practices with the financial imperatives of the Trust and increased control and accuracy in recording sickness/absence.

jakleeds
17/2/2010
17:16
Allocate Software Appoints Chris Gale as Chief Financial Officer

15 Feb 2010

Allocate Software is pleased to announce that Chris Gale has taken up his post of chief financial officer, joining the Board with immediate effect. His appointment was announced along with strong interim results on Friday 29th January 2010.

This appointment comes at a time when Allocate has begun its international expansion, following the recent acquisition of TimeCare, and Chris brings a wealth of experience transacting deals in Europe and North America. Chris has held senior financial roles in international public companies within the IT industry including: Apple Inc (in USA & European HQ), Cooper and Chyan Technology Inc (USA), Cadence Design Systems (USA & Europe), Interwoven and Clearswift (UK). In his most recent corporate role, Chris was CFO and acting CEO of GFI, a global software and hosted solutions company.

Ian Bowles, Chief Executive Officer commented: "I am delighted to welcome Chris to the Management Team. We have ambitious international expansion plans at Allocate Software and Chris brings with him a wealth of international and acquisition experience which will help us achieve our objectives. This appointment builds on the strength of the management team and provides additional international financial management and M&A experience which is required to take Allocate Software to its next level of growth."

jakleeds
17/2/2010
17:15
Allocate Software shortlisted for Healthcare Technology Group of the Year

12 Feb 2010

We are delighted to have been selected as a finalist for the HealthInvestor Awards 2010n in the Healthcare Technology Group category. HealthInvestor magazine is one of the UK healthcare industry's most respected information source which gives the latest news on all important political and business developments, analysis of key events and features that offer in-depth examinations of the industry's hot topics.

The finalist nominations will now be passed to an independent judging panel, with the winner announced at the black tie Awards dinner at the Hilton Park Lane on Thursday 27 May 2010.

For more information on these awards and HealthInvestor please visit

www.healthinvestor.co.uk

Here's the link to the shortlist:

jakleeds
15/2/2010
20:24
Thanks for that Steadyitgoes, here's the summary:

Feb 15th 2010 - Edison Investment Research today published a report on Allocate Software (ALL.L, LSE:ALL) entitled "Good Health". In summary, the report says:

Allocate Software posted strong H1 results, with revenues from the healthcare sector growing particularly well. There is still plenty to shoot for in the UK, with additional products and greater penetration of NHS Trusts. December's acquisition of Swedish company Time Care, funded by an oversubscribed placing, has continued the international expansion of the business. The valuation ignores the inherent value of the installed base and our DCF indicates a price of 100p.

jakleeds
15/2/2010
10:00
Report just published:
steadyitgoes
12/2/2010
16:32
interesting volume ie just over 1m so far. Presumably institutional with an envisaged RNS within a day or two.
gregmorg
11/2/2010
22:13
South West Yorkshire Partnership NHS Foundation Trust Selects Healthroster

9th Feb 2010

South West Yorkshire Partnership NHS Foundation Trust are a specialist NHS foundation trust that provides mental health and learning disability services to the people of Calderdale, Kirklees and Wakefield; serving a population of 900,000 across urban and rural communities from a range of diverse backgrounds. The Trust also provides some medium secure (forensic) services to the whole of Yorkshire and the Humber.


The Trust, which was first established in 2002, now employs more than 1,700 clinical staff and around 600 staff who provide non-clinical support services

jakleeds
04/2/2010
12:05
Interesting slant on ALL published a couple of weeks ago:-
"
Allocate Software

Other companies that PSQ predicts to establish the new world order in technology included workforce optimisation solutions provider Allocate Software (AIM: ALL), which targets the public sector, specifically the healthcare, defence and maritime segments. The company's prime focus is on the healthcare sector, which accounted for 70% of its revenues in 2009, while its MAPS Healthroster and Bank Staff Management Solutions (BSMS) are the leading e-rostering and temporary staffing solutions used by the NHS, with the company currently boasting a client base of 180 NHS trusts.

Strong product acceptance and growing contribution from services such as training and product support were listed as Allocate's strengths, while the opportunities included geographic expansion, diversification across sectors and growth through acquisitions."

Full link:-

mudbath
03/2/2010
11:07
ALL highlight the adjusted figures,when reporting;yet it is the pre-adjusted figures which are generally quoted for comparative,or statistical purposes.
WSI,a similar outfit in which I have an interest,do not quote on a basis of "adjusted" figures when reporting.
Edisons will be issuing revised forecasts for WSI in due course,when it will be interesting to consider/compare their updated research on both companies.

mudbath
02/2/2010
12:28
GBP'000 GBP'000 GBP'000
09I 08I 09Y
Profit for the year attributable to shareholders 483 635 3,047
Amortisation of intangibles 406 145 678
Share-based payment 39 52 97
Deferred tax adjustment - - (1,302)
Adjusted profit for the year attributable to s/hdrs 928 832 2,520

Basic adjusted earnings per share 2.1p 1.9p 5.64p
Diluted adjusted earnings per share 1.9p 1.8p 5.36p

See earlier post.The upload on the figs got garbled so trying again. However its all in the interim statement anyway.

gregmorg
02/2/2010
12:19
I am still no nearer to working out the brokers forecasts but realised that historic figures on EPS and the adjustments were included in the interim statement and they give a better picture. Problem is certain of these items will be ongoing for a while so that impacts the headline figures .

"Adjusted earnings per ordinary share

An adjusted earnings per share has been calculated in addition to the post tax
earnings per share, which eliminates the effects of share-based payments, goodwill, amortisation of intangibles and restructuring costs attributable
to acquisitions. It has been calculated to allow shareholders to gain a clearer understanding of the trading performance of the group. The basis of the calculation of the basic and adjusted profit per share is set out
below: "

Interims Interims YEAR 2009 2008 2009
GBP'000 GBP'000 GBP'000

Profit for the year attributable to shareholders 483 635 3,047
Amortisation of intangibles 406 145 678
Share-based payment 39 52 97
Deferred tax adjustment - - (1,302)
Adjusted profit for the year attributable to shareholders 928 832 2,520

Basic adjusted earnings per share 2.1p 1.9p 5.64p
Diluted adjusted earnings per share 1.9p 1.8p 5.36p

gregmorg
Chat Pages: Latest  16  15  14  13  12  11  10  9  8  7  6  5  Older

Your Recent History

Delayed Upgrade Clock